Brigatinib (Compound)

Synonyms:Brigatinib, 1197953-54-0, ALUNBRIG, AP-26113, Brigatinib [USAN], UNII-HYW8DB273J, HYW8DB273J, Brigatinib (AP-26113), AP 26113, (2-((5-chloro-2-((2-methoxy-4-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)phenyl)amino)pyrimidin-4-yl)amino)phenyl)dimethylphosphine oxide

Pubchem:PUBCHEM:68165256

Id:6b045874-25f0-5e78-8bc1-0c017c964d04

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View Brigatinib's neighborhood in the knowledge graph.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for Brigatinib.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with Brigatinib.

Results found

Linked to

	Label	Description
	brigatinib negatively regulates KRT19 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	brigatinib in similarity relationship with wortmannin Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Brigatinib bioactivity ALK tyrosine kinase receptor Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	brigatinib positively regulates TMPRSS3 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	brigatinib (11ee53b4-63ad-4564-b674-aa61e4cd893e) Collection (Entity type)	Metadatata for brigatinib
	Brigatinib bioactivity Receptor-type tyrosine-protein kinase FLT3 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	brigatinib positively regulates PRUNE2 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	brigatinib positively regulates SCGB1D2 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	brigatinib negatively regulates PLA2G2A Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	brigatinib positively regulates AZGP1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS

brigatinib negatively regulates KRT19

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from LINCS

brigatinib in similarity relationship with wortmannin

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from LINCS

Brigatinib bioactivity ALK tyrosine kinase receptor

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

brigatinib positively regulates TMPRSS3

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from LINCS

brigatinib (11ee53b4-63ad-4564-b674-aa61e4cd893e)

Collection (Entity type)

Metadatata for brigatinib

Brigatinib bioactivity Receptor-type tyrosine-protein kinase FLT3

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

brigatinib positively regulates PRUNE2

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from LINCS

brigatinib positively regulates SCGB1D2

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from LINCS

brigatinib negatively regulates PLA2G2A

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from LINCS

brigatinib positively regulates AZGP1

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from LINCS

DISPLAY PER PAGE

CFDE Workbench

Consortium

Community

Resources

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

CFDE Workbench

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.